Crizac Limited (NSE:CRIZAC)

Elevation Oncology Revenue

Crizac had revenue of 2.18B INR in the quarter ending June 30, 2025, with 23.25% growth. This brings the company's revenue in the last twelve months to 8.91B, up 42.49% year-over-year. In the fiscal year ending March 31, 2025, Crizac had annual revenue of 8.49B with 60.27% growth.

• Revenue (ttm): 8.91B
• Revenue Growth: +42.49%
• P/S Ratio: 6.01
• Revenue / Employee: 24.20M
• Employees: 368
• Market Cap: 53.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	8.49B	3.19B	60.27%
Mar 31, 2024	5.30B	2.56B	93.38%
Mar 31, 2023	2.74B	1.54B	128.28%
Mar 31, 2022	1.20B	912.91M	317.21%
Mar 31, 2021	287.79M	172.93M	150.57%